Silke Markau

839 total citations
21 papers, 289 citations indexed

About

Silke Markau is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Silke Markau has authored 21 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Silke Markau's work include Chronic Kidney Disease and Diabetes (6 papers), Dialysis and Renal Disease Management (6 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Silke Markau is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Dialysis and Renal Disease Management (6 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Silke Markau collaborates with scholars based in Germany, United States and South Korea. Silke Markau's co-authors include Matthias Girndt, Andreas Stang, Pietro Trocchi, Christa Scheidt‐Nave, G. Haensgen, Juergen Dunst, Axel Becker, Eric Seibert, Heike E. F. Becker and Christine Lautenschläger and has published in prestigious journals such as Journal of the American College of Cardiology, International Journal of Molecular Sciences and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Silke Markau

20 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silke Markau Germany 10 97 69 51 49 46 21 289
Samra Abouchacra United Arab Emirates 12 93 1.0× 81 1.2× 41 0.8× 38 0.8× 86 1.9× 28 304
Gaetano Lucisano Italy 13 166 1.7× 84 1.2× 60 1.2× 30 0.6× 30 0.7× 23 407
Alastair J. Rankin United Kingdom 10 74 0.8× 48 0.7× 41 0.8× 51 1.0× 83 1.8× 25 315
Amrish Jain United States 10 75 0.8× 45 0.7× 117 2.3× 29 0.6× 60 1.3× 24 318
A Tato Spain 9 118 1.2× 75 1.1× 68 1.3× 26 0.5× 44 1.0× 31 327
Pradeep Vaitla United States 10 119 1.2× 61 0.9× 51 1.0× 53 1.1× 16 0.3× 35 295
Shina Lee South Korea 9 222 2.3× 52 0.8× 50 1.0× 23 0.5× 60 1.3× 21 347
Sinan Trabulus Türkiye 11 113 1.2× 75 1.1× 72 1.4× 19 0.4× 23 0.5× 59 381
Janice Chew‐Harris New Zealand 10 159 1.6× 34 0.5× 35 0.7× 18 0.4× 51 1.1× 18 329
Gülay Ulusal Okyay Türkiye 9 144 1.5× 31 0.4× 73 1.4× 25 0.5× 74 1.6× 28 358

Countries citing papers authored by Silke Markau

Since Specialization
Citations

This map shows the geographic impact of Silke Markau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Markau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Markau more than expected).

Fields of papers citing papers by Silke Markau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Markau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Markau. The network helps show where Silke Markau may publish in the future.

Co-authorship network of co-authors of Silke Markau

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Markau. A scholar is included among the top collaborators of Silke Markau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Markau. Silke Markau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ulrich, Christof, et al.. (2024). Hypervolemia in Dialysis Patients Impairs STAT3 Signaling and Upregulates miR-142-3p: Effects on IL-10 and IL-6. International Journal of Molecular Sciences. 25(7). 3719–3719. 1 indexed citations
3.
Ulrich, Christof, Roman Fiedler, Eric Seibert, et al.. (2021). Pyroptosis: A Common Feature of Immune Cells of Haemodialysis Patients. Toxins. 13(12). 839–839. 5 indexed citations
4.
Ulrich, Christof, Roman Fiedler, Eric Seibert, et al.. (2020). NLRP3 Inflammasome Activation in Hemodialysis and Hypertensive Patients with Intact Kidney Function. Toxins. 12(11). 675–675. 16 indexed citations
5.
Girndt, Matthias, Silke Markau, Alberto Breda, et al.. (2019). Minimally invasive robotic versus conventional open living donor kidney transplantation. World Journal of Urology. 38(3). 795–802. 30 indexed citations
6.
Markau, Silke, et al.. (2018). Influence of SPRINT Study Type Automated Office Blood Pressure Measurements on Hypertension Diagnosis in Kidney Transplant Patients. Kidney & Blood Pressure Research. 43(2). 310–317. 3 indexed citations
7.
Trocchi, Pietro, Matthias Girndt, Christa Scheidt‐Nave, Silke Markau, & Andreas Stang. (2017). Impact of the estimation equation for GFR on population-based prevalence estimates of kidney dysfunction. BMC Nephrology. 18(1). 341–341. 12 indexed citations
8.
Girndt, Matthias, Pietro Trocchi, Christa Scheidt‐Nave, Silke Markau, & Andreas Stang. (2016). The Prevalence of Renal Failure. Deutsches Ärzteblatt international. 113(6). 85–91. 66 indexed citations
9.
Girndt, Matthias, Pietro Trocchi, Christa Scheidt‐Nave, Silke Markau, & Andreas Stang. (2016). Prävalenz der eingeschränkten Nierenfunktion. Publication server of the Robert Koch Institute (Robert Kock Institute). 10 indexed citations
10.
Seibert, Eric, et al.. (2016). Clinical Course of Acute Kidney Injury in Elderly Individuals Above 80 Years. Kidney & Blood Pressure Research. 41(6). 947–955. 15 indexed citations
11.
Girndt, Matthias, et al.. (2014). Parameters Influencing Waiting Time for a Deceased Donor Kidney in the Eurotransplant Allocation System.. Transplantation. 98. 648–648. 1 indexed citations
12.
Pliquett, Rainer U., et al.. (2012). Plasmapheresis leading to remission of refractory nephrotic syndrome due to fibrillary glomerulonephritis: a case report. Journal of Medical Case Reports. 6(1). 116–116. 5 indexed citations
13.
Fiedler, Roman, et al.. (2011). Vitamin D Deficiency, Mortality, and Hospitalization in Hemodialysis Patients with or without Protein-Energy Wasting. Nephron Clinical Practice. 119(3). c220–c226. 14 indexed citations
14.
Fiedler, Roman, et al.. (2007). Bestimmung der Nierenfunktion im klinischen Alltag - welche Methode ist die beste?. DMW - Deutsche Medizinische Wochenschrift. 132(20). 1093–1097. 4 indexed citations
15.
Hamza, Amir, et al.. (2007). Ten Years of Laparoscopic Living Donor Nephrectomy: Retrospect and Prospect From the Nephrologist’s Point of View. Transplantation Proceedings. 39(1). 30–33. 10 indexed citations
16.
Kornhuber, M. E., et al.. (2006). Pseudotumor cerebri due to proximal haemodialysis fistula. Nephrology Dialysis Transplantation. 22(2). 654–654. 5 indexed citations
17.
Kühn, Christian, Silke Markau, & B Osten. (2005). Abszedierende Pneumonie bei einer nierentransplantierten Patientin. Der Internist. 46(7). 789–794. 2 indexed citations
18.
Dunst, Juergen, Axel Becker, Christine Lautenschläger, et al.. (2002). Anemia and Elevated Systemic Levels of Vascular Endothelial Growth Factor (VEGF). Strahlentherapie und Onkologie. 178(8). 436–441. 59 indexed citations
19.
Dhein, Stefan, Silke Markau, Karin Becker, et al.. (2000). Cardiac beta-adrenoceptors in chronic uremia: studies in humans and rats. Journal of the American College of Cardiology. 36(2). 608–617. 24 indexed citations
20.
Dunst, Juergen, Eliane Fischer, Silke Markau, Axel Becker, & G. Haensgen. (2000). Vascular endothelial growth factor (VEGF) in sera and plasma of tumor-patients and the impact of hemogobin. International Journal of Radiation Oncology*Biology*Physics. 48(3). 125–125. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026